NeuroMetrix

NURO NASDAQ
0.6351
-0.0088
-1.37%
已收盘, 16:00 05/20 EDT
开盘
0.6438
昨收
0.6439
最高
0.6700
最低
0.6351
成交量
6.24万
成交均量(3M)
13.63万
52周最高
1.770
52周最低
0.6000
换手率
0.71%
市值
560.18万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供NeuroMetrix NURO股票价格,NeuroMetrix股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.
展开 >

最近浏览

名称
价格
涨跌幅